Companies: 10,795·Total market cap: $144.5T
Generation Bio Co.

Generation Bio Co.

GBIONASDAQHealthcare
$5.34
+$0.00(+0.00%)
Market Cap$35983830
P/E Ratio
52W High$7.516
52W Low$3.004
Overview

Generation Bio Co. (GBIO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

gbio · stock forecast · 10 analysts (3M) · FMP · updated Mar 26, 2026

Analyst Rating & Consensus

Based on 10 Wall Street analysts in the past 3 months

SellBuy

Buy

10 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
5
Sell
0
Strong Sell
0
Total: 10 · Buy rate: 50.0%

12-Month Price Target

High

$5.50

Consensus

$5.25

-1.7% upside

Low

$5.00

Median: $5.25 · Last Close: $5.34

The Generation Bio Co. (GBIO) analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month GBIO price target is $5.25, representing -1.7% upside from the current price of $5.34.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $5 (-1.7%)

Consensus Target

$5.25

-1.7% upside

High Target

$5.5

3.0%

Low Target

$5

-6.4%

Current Price

$5.34

as of today

Based on analyst price targets, the GBIO stock price prediction for the next 12 months ranges from $5 to $5.5. The consensus GBIO price forecast of $5.25 implies -1.7% upside from the current price of $5.34.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$5.281.17%

1-day model range: $5.23–$5.33. Peak: $5.33 (-1.17%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-50.0%
2028-62.5%
2029-67.2%
2030-69.2%
2031-70.2%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)44.5
MACDBEARISH

Moving Averages · GBIO · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$5.48SELL
MA 10$5.55SELL
MA 20$5.59SELL
MA 50$5.49SELL
MA 100$5.64SELL
MA 200$5.09BUY
Current $GBIO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.44SELL
EMA 10$5.51SELL
EMA 20$5.54SELL
EMA 50$5.54SELL
EMA 100$5.55SELL
EMA 200$6.39SELL
Current $GBIO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wedbush2025-12-16
Upgrade ↑
NeutralOutperform
Jefferies2025-12-16
Downgrade ↓
BuyHold
Canaccord Genuity2025-08-18
Maintains
BuyBuy
Needham2025-08-13
Maintains
BuyBuy
Wedbush2025-08-13
Downgrade ↓
OutperformNeutral
Needham2025-05-08
Maintains
BuyBuy
Needham2025-04-10
Maintains
BuyBuy
Canaccord Genuity2025-03-17
Maintains
BuyBuy
Citizens Capital Markets2025-03-14
Maintains
Market PerformMarket Perform
Needham2025-03-14
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Generation Bio Co. (GBIO) stock. Of the recent 46 rating actions, 1 were upgrades and 4 were downgrades. 10 analysts currently cover GBIO.

Analyst Recommendation Trends

Buy ratings11
Hold ratings01↑ +1
Sell ratings00

GBIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$11M

↑ 0.0% YoY

Revenue Next Year

$4M

↓ 66.7% YoY

EPS This Year

$-9.58

EPS Next Year

$-3.72

↓ 61.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GBIO EPS of $-9.58 for the current fiscal year, based on estimates from 1 analysts. The GBIO revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The GBIO stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GBIO price target is $5.25 (-1.7% upside), with an analyst consensus of Buy.

The GBIO short-term stock prediction for tomorrow is $5.28 (-1.17%). The GBIO stock prediction for 2030 projects a range of $2–$2.

Generation Bio Co. trades on NASDAQ under the ticker GBIO. The GBIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

GBIO forecast · 8 questions

According to 10 Wall Street analysts, the average 12-month GBIO price target is $5.25, with a high forecast of $5.50 and a low of $5.00. The median price target is shown in the chart above when available. This implies -1.7% potential upside from the current price of $5.34.

GBIO price targetWhat is GBIO price targetGBIO analyst price targetGBIO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.